Načítá se...
Applying proteomic technology to clinical virology
Developing antiviral drugs, vaccines and diagnostic markers is still the most ambitious challenge in clinical virology. In the past few decades, data from high‐throughput technologies have allowed for the rapid development of new antiviral therapeutic strategies, thus making a profound impact on tra...
Uloženo v:
| Vydáno v: | Clin Microbiol Infect |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Blackwell Publishing Ltd
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7129767/ https://ncbi.nlm.nih.gov/pubmed/23034105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1469-0691.12029 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|